Exosomes are small biological particle secreted by cells, from which they inherit some key therapeutic properties. Stem-cells derived exosomes, in particular, are able to virtually replicate the regenerative properties of their parent cells, while drastically simplifying logistics.
Compared to stem cells, exosome-based treatments offer simpler and more cost-efficient logistics, and greater ease of use for clinicians.
For patients, research has shown that exosomes have a more advantageous risk profile compared to stem cells : no donor rejection, no proliferation or differentiation risks.
Lastly, exosomes are perfectly suited for engineering, which enables significant improvements of their targeting , cell penetrating and cargo delivery properties.